ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,429Medicare Part D Prescriptions Filled, Including Refills

Rank: 172 out of 761

$521K Total Retail Price of All Prescriptions

Rank: 116 out of 761

499 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
5% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 499 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 499 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 8,019 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
SIMVASTATIN 341 332 1 2
HYDROCODONE-ACETAMINOPHEN 325 293 S3 2 5
AMLODIPINE BESYLATE 257 257 3 6
LEVOTHYROXINE SODIUM 250 240 4 3
ATORVASTATIN CALCIUM 221 213 5 12
ZOLPIDEM TARTRATE 221 211 5 22
HYDROCHLOROTHIAZIDE 190 189 7 11
WARFARIN SODIUM 179 179 8 9
LISINOPRIL 174 171 9 1
TRIAMTERENE-HCTZ 162 162 10 42
FUROSEMIDE 161 160 11 7
ATENOLOL 158 158 12 8
OMEPRAZOLE 144 136 13 4
POTASSIUM CHLORIDE 143 138 14 18
PRAVASTATIN SODIUM 136 127 15 20
DICLOFENAC SODIUM 125 123 16 142
METFORMIN HCL 124 118 17 10
SERTRALINE HCL 124 107 17 25
METOPROLOL SUCCINATE 115 115 19 16
QUINAPRIL HCL 104 103 20 156
TAMSULOSIN HCL 92 92 21 27
TRAZODONE HCL 90 88 22 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 89 78 23 35
BENICAR HCT 88 73 24 215
DOXAZOSIN MESYLATE 87 87 25 55
LOSARTAN-HYDROCHLOROTHIAZIDE 86 83 26 65
ADVAIR DISKUS 82 78 27 37
BENICAR 79 79 28 81
LIPITOR 71 71 29 147
CITALOPRAM HBR 70 70 30 19
LOVASTATIN 70 68 30 17
ATENOLOL-CHLORTHALIDONE 69 62 32 298
AZITHROMYCIN 69 65 32 70
CRESTOR 61 50 34 36
LOSARTAN POTASSIUM 61 61 34 13
METOPROLOL TARTRATE 60 60 36 14
TRAMADOL HCL 57 53 37 34
CYCLOBENZAPRINE HCL 57 44 R 37 51
DIOVAN HCT 56 55 39 155
ALENDRONATE SODIUM 55 55 40 21
SYNTHROID 55 54 40 64
AMITRIPTYLINE HCL 52 50 R 42 54
ALLOPURINOL 51 51 43 28
CYMBALTA 51 34 43 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.